Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1 L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study - Moehler, M; Shitara, K; Garrido, M (Ann Oncol, 2020)
Abstract LBA6_PR